Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients

Inclusion Criteria

• •1. Recipients of de novo cadaveric, living unrelated or living related kidney transplants
• •2. Females capable of becoming pregnant must have a negative serum pregnancy test within 7 days prior to or at baseline, and are required to practice an approved method of birth control for the duration of the study and for a period of 6 weeks following discontinuation of study medication, even where there has been a history of infertility.
• •3. Patients who are willing and able to participate in the study and from whom written informed consent has been obtained.